1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
2024) In Science (New York, N.Y.)(
- Contribution to journal › Article
- 2023
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
- 2021
-
Mark
Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes
(
- Contribution to journal › Article
-
Mark
Immune delineation of laryngeal papilloma reveals enhanced neutrophil associated gene profile
(
- Contribution to journal › Letter
-
Mark
Tonsillar cancer with high cd8+ t‐cell infiltration features increased levels of dendritic cells and transcriptional regulation associated with an inflamed tumor microenvironment
(
- Contribution to journal › Article
- 2020
-
Mark
An integrated transcriptomic- and proteomic-based approach to evaluate the human skin sensitization potential of glyphosate and its commercial agrochemical formulations
(
- Contribution to journal › Article
-
Mark
Changes in Intestinal Permeability Ex Vivo and Immune Cell Activation by Three Commonly Used Emulsifiers
(
- Contribution to journal › Article
- 2018
-
Mark
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes
(
- Contribution to journal › Article